MedTrace Logo

Efficacy and Safety of Two Doses of Hipnos in the Treatment of Adults With Insomnia

NCT03814135 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2021-04-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of three doses of Hipnos medication in adults with insomnia.

Conditions

Interventions

DRUG

Hipnos 3

1 tablet, oral, once a day.

DRUG

Hipnos 5

1 tablet, oral, once a day.

OTHER

Hipnos 5 Placebo

1 tablet, oral, once a day.

OTHER

Hipnos 3 Placebo

1 tablet, oral, once a day.

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-31
Primary Completion
2022-02-28
Completion
2022-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03814135 on ClinicalTrials.gov